These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10485989)

  • 1. Alfacalcidol and calcitriol in the prevention of bone loss after organ transplantation.
    Sambrook P
    Calcif Tissue Int; 1999 Oct; 65(4):341-3. PubMed ID: 10485989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
    Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol.
    Schacht E
    Calcif Tissue Int; 1999 Oct; 65(4):317-27. PubMed ID: 10485985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY; Lecart MP; Richy F
    J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures.
    Schacht E; Richy F; Reginster JY
    J Musculoskelet Neuronal Interact; 2005; 5(3):273-84. PubMed ID: 16172518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-hormones for prevention of bone loss after organ transplant.
    Sambrook PN
    J Rheumatol Suppl; 2005 Sep; 76():41-3. PubMed ID: 16142850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Osteoporosis after solid organs transplantation].
    Cipriani R; Farias ML
    Arq Bras Endocrinol Metabol; 2005 Jun; 49(3):369-77. PubMed ID: 16543990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-transplantation osteoporosis.
    Stein E; Ebeling P; Shane E
    Endocrinol Metab Clin North Am; 2007 Dec; 36(4):937-63; viii. PubMed ID: 17983930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation osteoporosis.
    Ebeling PR
    Curr Osteoporos Rep; 2007 Mar; 5(1):29-37. PubMed ID: 17320025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol.
    Ringe JD; Schacht E
    Rheumatol Int; 2004 Jul; 24(4):189-97. PubMed ID: 15232715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate.
    Richy F; Ethgen O; Bruyere O; Reginster JY
    Osteoporos Int; 2004 Apr; 15(4):301-10. PubMed ID: 14740153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis after solid organ transplantation.
    Kulak CA; Cochenski Borba VZ; Kulak J; Ribeiro Custódio M
    Minerva Endocrinol; 2012 Sep; 37(3):221-31. PubMed ID: 22766889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.
    Shane E; Rodino MA; McMahon DJ; Addesso V; Staron RB; Seibel MJ; Mancini D; Michler RE; Lo SH
    J Heart Lung Transplant; 1998 Nov; 17(11):1089-96. PubMed ID: 9855448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of bone loss after organ transplantation.
    Cohen A; Sambrook P; Shane E
    J Bone Miner Res; 2004 Dec; 19(12):1919-32. PubMed ID: 15537434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
    Jones G; Hogan DB; Yendt E; Hanley DA
    CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid induced osteoporosis.
    Sambrook PN
    J Rheumatol Suppl; 1996 Aug; 45():19-22. PubMed ID: 8856647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the outcome of established therapies for osteoporosis by adding the active D-hormone analog alfacalcidol.
    Ringe JD; Schacht E
    Rheumatol Int; 2007 Dec; 28(2):103-11. PubMed ID: 17668216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined therapies in osteoporosis: bisphosphonates and vitamin D-hormone analogs.
    Schacht E; Dukas L; Richy F
    J Musculoskelet Neuronal Interact; 2007; 7(2):174-84. PubMed ID: 17627088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral calcitriol versus oral alfacalcidol for the treatment of secondary hyperparathyroidism in patients receiving hemodialysis: a randomized, crossover trial.
    Moe S; Wazny LD; Martin JE
    Can J Clin Pharmacol; 2008; 15(1):e36-43. PubMed ID: 18192704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone disease in organ transplant patients: pathogenesis and management.
    Chauhan V; Ranganna KM; Chauhan N; Vaid M; Kelepouris E
    Postgrad Med; 2012 May; 124(3):80-90. PubMed ID: 22691902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.